MCAT Biochemistry Lipid Metabolism Review

Lipid metabolism is a central pillar of biochemistry with profound clinical implications, making it a high-yield topic for the MCAT. Mastering this content is essential not only for answering discrete questions but also for interpreting complex experimental passages on the Biological and Biochemical Foundations of Living Systems section. Your understanding of how the body synthesizes, degrades, and transports fats is key to connecting biochemistry to physiology and disease states like atherosclerosis, diabetic ketoacidosis, and hypercholesterolemia.

Fatty Acid Catabolism: Beta-Oxidation

The primary pathway for degrading fatty acids to generate energy is beta-oxidation, a cyclical process located in the mitochondrial matrix. Before entering this pathway, fatty acids must be activated in the cytosol. They are coupled to coenzyme A (CoA) to form fatty acyl-CoA, a reaction catalyzed by acyl-CoA synthetase that consumes two ATP equivalents (forming AMP). The fatty acyl-CoA then cannot cross the inner mitochondrial membrane on its own; it requires the carnitine shuttle. Carnitine palmitoyltransferase I (CPT-I) on the outer mitochondrial membrane transfers the acyl group to carnitine. The acyl-carnitine is translocated across the inner membrane via a translocase, and CPT-II on the matrix side regenerates fatty acyl-CoA.

Once inside, beta-oxidation proceeds through four repeated steps: oxidation, hydration, oxidation, and thiolysis. Each cycle releases one molecule of acetyl-CoA and produces one FADH2 (from the first oxidation step, catalyzed by acyl-CoA dehydrogenase) and one NADH (from the second oxidation step, catalyzed by beta-hydroxyacyl-CoA dehydrogenase). The remaining fatty acyl chain, now shortened by two carbons, re-enters the cycle. For a saturated 16-carbon palmitic acid, seven cycles of beta-oxidation yield eight acetyl-CoA, seven FADH2, and seven NADH. These products then feed into the citric acid cycle and electron transport chain for massive ATP production.

MCAT Passage Tip: Experimental passages often use radiolabeled fatty acid tracking studies. For example, if a fatty acid is labeled with carbon-14 at the carbonyl carbon (C-1), that label will appear in the acetyl-CoA produced in the final thiolysis step of beta-oxidation. If it is labeled at the methyl terminal (the omega carbon), the label will appear in the first acetyl-CoA released. Tracking these labels through subsequent pathways like the citric acid cycle helps deduce metabolic flux.

Fatty Acid Anabolism: The Fatty Acid Synthase Complex

Fatty acid synthesis is not simply the reverse of beta-oxidation. It is a separate pathway occurring in the cytoplasm, using a different set of enzymes and cofactors. The key enzyme is the fatty acid synthase complex, a multifunctional protein in mammals. Its primary substrate for chain elongation is not acetyl-CoA directly, but malonyl-CoA. Acetyl-CoA carboxylase (ACC) catalyzes the committed, rate-limiting step: the ATP-dependent carboxylation of acetyl-CoA to form malonyl-CoA.

The synthase complex then performs repeated cycles of condensation, reduction, dehydration, and reduction. The two-carbon donor in each cycle is malonyl-CoA, which loses CO2 during condensation. The reducing power comes from NADPH, not NADH or FADH2. This highlights a critical regulatory and compartmentalization concept: degradation in the mitochondria uses NAD+/FAD, while synthesis in the cytosol uses NADPH. After seven cycles, a 16-carbon palmitate is released. This separation allows for independent hormonal regulation: insulin promotes synthesis (via activating ACC), while glucagon and epinephrine promote degradation.

Ketone Body Metabolism

During prolonged fasting, starvation, or untreated type 1 diabetes, the liver converts excess acetyl-CoA derived from fatty acid oxidation into ketone bodies: acetoacetate, beta-hydroxybutyrate, and acetone. This occurs because hepatic beta-oxidation outpaces the citric acid cycle's capacity, often due to low oxaloacetate levels diverted to gluconeogenesis. Ketogenesis provides a water-soluble, exportable fuel source for extrahepatic tissues, most critically the brain and heart.

The liver mitochondria synthesize ketone bodies but cannot use them; it lacks the enzyme thiophorase. Tissues like cardiac muscle, skeletal muscle, and the brain (especially during starvation) take up ketone bodies and convert them back to acetyl-CoA for the citric acid cycle. This is a vital survival mechanism. However, overproduction, as in diabetic ketoacidosis, leads to a dangerous metabolic acidosis.

MCAT Application: You must understand the metabolic conditions that favor ketogenesis (low insulin, high glucagon, high acetyl-CoA, low oxaloacetate) versus lipogenesis (high insulin, abundant carbohydrates). A passage might present blood chemistry data and ask you to diagnose a metabolic state based on elevated ketone and fatty acid levels.

Lipoprotein Metabolism and Transport

Because lipids are hydrophobic, they are transported in the bloodstream as part of lipoproteins. These are complex particles with a hydrophobic core (triglycerides and cholesteryl esters) and an amphipathic shell (phospholipids, free cholesterol, and apolipoproteins). Apolipoproteins serve as structural components, enzyme cofactors, and receptor ligands, directing lipoprotein metabolism.

The major classes form a transport system:

• Chylomicrons: Carry dietary triglycerides from the intestine to peripheral tissues. Lipoprotein lipase (LPL) on capillary endothelial cells hydrolyzes the triglycerides, releasing free fatty acids for uptake.
• VLDL (Very Low-Density Lipoprotein): Transport hepatic triglycerides to peripheral tissues. As VLDL loses triglycerides, it becomes IDL and then LDL (Low-Density Lipoprotein).
• LDL: The major cholesterol carrier in blood. It delivers cholesterol to peripheral tissues via LDL receptor-mediated endocytosis. High LDL is a primary risk factor for atherosclerosis.
• HDL (High-Density Lipoprotein): Synthesized by the liver and intestine, it performs reverse cholesterol transport, scavenging excess cholesterol from tissues and arterial plaques and returning it to the liver for excretion (in bile). High HDL is considered protective.

Cholesterol Synthesis and Regulation

Cholesterol synthesis is a cytosolic and endoplasmic reticulum pathway that begins with acetyl-CoA. The key regulated and rate-limiting step is the conversion of HMG-CoA to mevalonate, catalyzed by HMG-CoA reductase. This enzyme is the target of statin drugs. Its activity is regulated at multiple levels:

• Transcriptional Control: High cellular cholesterol levels downregulate gene expression via the SREBP (Sterol Regulatory Element-Binding Protein) system.
• Post-Translational Control: AMP-activated protein kinase (AMPK) phosphorylates and inactivates HMG-CoA reductase when cellular energy is low.
• Degradation: High sterol levels accelerate enzyme degradation.

Cholesterol is vital for membrane fluidity and is the precursor for all steroid hormones, bile acids, and vitamin D. Its synthesis and uptake via LDL receptors are tightly coordinated to maintain homeostasis.

Common Pitfalls

1. Confusing the Cellular Compartments and Cofactors for Synthesis vs. Degradation. A classic MCAT trap is to mix up the locations and electron carriers. Remember: Beta-oxidation is in the mitochondria and uses NAD+ and FAD. Fatty acid synthesis is in the cytoplasm and uses NADPH. If a question asks about the effect of a mitochondrial NADH/NAD+ inhibitor, it impacts oxidation, not synthesis.

1. Misunderstanding the Role of Ketone Bodies. Ketone bodies are not waste products; they are crucial alternative fuels. The liver produces but does not use them. The brain can use them during starvation, which is a critical adaptation to spare glucose and muscle protein.

1. Mixing Up Lipoprotein Functions. It's easy to confuse which particle is "good" or "bad" and why. Focus on their origin and destiny: LDL arises from VLDL and delivers cholesterol to arteries. HDL is made from scratch and takes cholesterol away from arteries to the liver. Knowing the primary apolipoproteins (like ApoB-48 for chylomicrons, ApoB-100 for VLDL/LDL, and ApoA-I for HDL) can help you track them in a passage.

1. Overlooking Hormonal Regulation Context. Never analyze a lipid pathway in isolation. Insulin simultaneously promotes fatty acid synthesis (by activating ACC) and inhibits lipolysis in adipose tissue. Glucagon has the opposite effect. Always tie the biochemical pathway activity back to the organism's fed or fasted state.

Summary

• Beta-oxidation in mitochondria breaks down fatty acids into acetyl-CoA, generating FADH2 and NADH for the ETC. Activation requires the carnitine shuttle.
• Fatty acid synthesis occurs in the cytoplasm via the fatty acid synthase complex, using acetyl-CoA and malonyl-CoA with NADPH as the reductant.
• Ketone bodies (acetoacetate, beta-hydroxybutyrate) are synthesized in the liver from acetyl-CoA during fasting and used as fuel by peripheral tissues, including the brain.
• Lipoproteins are transport vehicles: chylomicrons (dietary TG), VLDL (hepatic TG), LDL (cholesterol delivery), and HDL (reverse cholesterol transport).
• Cholesterol synthesis is regulated at HMG-CoA reductase, controlled by SREBP, AMPK, and sterol feedback.
• For MCAT passages, carefully track radiolabels in experiments, distinguish compartment-specific cofactors, and always link pathway activity to hormonal status (insulin vs. glucagon).